Daily FNArena News - Small Caps

Actinogen Medical is a biotech with a potentially “gazillion” dollar opportunity in its Alzheimer’s drug

A turn in sentiment has allowed Nanosonics shares to recover, with (some) broker views turning less negative

The headwinds that drove a soft FY22 for Select Harvests look to continue to challenge the company in the new fiscal year

United Malt’s FY22 was weak, as expected, but the company has guided to significant earnings growth ahead

Nufarm wraps up a strong year with guidance for modest growth ahead, surprising analysts who had largely predicted an earnings decline

Elders closes the year on a strong note, but heavy rainfall dampens the outlook for coming harvests

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player

Having brought a canine cancer treatment to market, Qbiotic’s focus has returned to treating two-legged cancers including melanoma and other difficult-to-treat cancers

Despite a weaker production result in its third quarter, Coronado Resources has benefitted from strong price realisation

Tim Boreham notes small caps with cash on the balance sheet are the safer bet compared to ‘pre-revenue’ companies, and highlights several examples